Walk into a recovery studio this autumn and the menu has a familiar shape: ice baths, compression boots, red-light panels — and, increasingly, an hour in a pressurised oxygen chamber. Hyperbaric oxygen therapy, a hospital treatment built around breathing near-pure oxygen at higher-than-atmospheric pressure, has crossed into the wellness market on a simple promise: faster recovery. A meta-analysis published this year, together with two unusually careful trials, gives a clearer sorting of that promise than the marketing does — including one detail about pressure levels that matters to anyone comparing equipment.
The hospital version, and the wellness version
In established medicine, hyperbaric oxygen therapy means breathing close to 100% oxygen inside a chamber pressurised to roughly two to two-and-a-half times normal atmospheric pressure. It is a regulated, prescribed treatment with a defined list of uses. The wellness version is looser: studios and home units, many of them soft-sided “mild” chambers running at much lower pressure with concentrated rather than pure oxygen, sold directly to people who train hard and want to bounce back faster. The two share a name and a principle — more oxygen dissolved into blood plasma — but they are not the same intervention, and the evidence does not treat them as one.
Injury recovery: a real, measured effect
The most comprehensive look at the question arrived in March in the Archives of Physical Medicine and Rehabilitation: a systematic review and meta-analysis pooling ten randomised controlled trials with 299 participants. Its headline finding favours the therapy. Hyperbaric oxygen significantly accelerated recovery from exercise-induced muscle injury (95% confidence interval −76.19 to −33.11; P<.0001), and the effect held across subgroups — at pressures above and at or below 2.0 atmospheres absolute (ATA), with 60- and 100-minute sessions, and in both college students and elite athletes.
The same analysis delivers the counterweight. For exercise-induced muscle soreness — the familiar ache a day or two after hard training — there was no significant benefit overall (95% CI −0.91 to 0.48; P=.54). Soreness eased only in specific subgroups: at pressures above 2.0 ATA (P=.05) and with 100-minute sessions (P=.01). At or below 2.0 ATA the estimate actually leaned toward the control condition, and 60-minute protocols showed no effect. “Helps injured muscle recover” is supported; “takes away next-day soreness” is, at best, conditional.
What access actually looks like
The clinical route runs through accredited hospital programmes and wound-care centres, where hyperbaric oxygen is prescribed for a defined set of conditions. The Undersea & Hyperbaric Medical Society maintains the reference list — 14 approved indications, from diabetic foot wounds and crush injuries to carbon monoxide poisoning and delayed radiation injury. Recovery from exercise is not among them; it sits in the investigational zone, which is why studio sessions and home units are an out-of-pocket market rather than an insurance-covered one.
That market is broad. A search for hyperbaric chambers for sale turns up everything from zip-up soft chambers running near 1.3 ATA to hard, clinical-grade systems rated for higher pressures. The spread is not just a pricing detail — it maps directly onto the evidence above. The soreness benefit in the meta-analysis appeared only above 2.0 ATA, a threshold soft mild-pressure chambers physically cannot reach, while the injury-recovery effect was demonstrated across pressure ranges. Anyone weighing a purchase or a studio membership is really choosing which part of that evidence base applies to the equipment in front of them, and a physician remains the right starting point for that conversation.
What the better trials saw
Two individual studies show the shape of the effect. A 2019 randomised trial in BioMed Research International enrolled 41 athletes with actual exercise-related muscle injuries — not lab-induced soreness — and gave them ten sessions of hyperbaric oxygen or a placebo treatment. By the tenth session the treatment group showed clear reductions in creatine phosphokinase, glutamic oxaloacetate transaminase and myoglobin, all blood markers of muscle damage, and the reductions were still present two weeks later. Pain intensity and pain interference improved in the treatment group only; the control group showed no statistical change on any measure.
A 2024 crossover study tested the milder end of the spectrum: 12 national-level university athletes cycled for 90 minutes, then spent an hour either in normal air or in a mild chamber at 1.25 ATA breathing 26–28% oxygen — conditions close to what wellness studios offer. The mild sessions reduced subjective fatigue and sped the recovery of heart rate and blood perfusion. But blood markers of muscle damage, metabolites and oxidative stress improved significantly only after six repeated sessions; a single session did little. The dose, in other words, is not one visit.
Why pressure plus oxygen might work at all
The biological rationale is plausible and increasingly mapped. A 2021 review in Biomolecules describes how intermittent hyperoxia acts as a controlled stressor: brief surges of reactive oxygen species work as signalling molecules that trigger adaptive, protective responses, and the anti-inflammatory effect observed after treatment may be mediated by hyperoxia interfering with the NF-κB and IκBα pathway, alongside effects on angiogenesis. The same chemistry explains the ceiling — oxygen is dose-dependent in both directions, which is why “more pressure, more often” is not a safe default and why clinical protocols exist at all.
Where the marketing overshoots
Three claims outrun the sources. The first is the blanket promise of “faster recovery”: the pooled data support faster recovery from muscle injury, not from ordinary soreness, and conflating the two is the most common sleight of hand in studio advertising. The second is the single-session sell — the mild-chamber trial found blood-marker improvements only after six sessions. The third is silence about pressure: a chamber’s ATA rating determines which evidence, if any, is relevant to it, and that number rarely makes it into the brochure copy.
What the evidence actually supports
Read together, the sources point to a narrow, genuinely interesting conclusion. Hyperbaric oxygen, in repeated sessions and at clinical pressures, appears to help injured muscle recover faster — with blood markers and pain scores to back it. For everyday soreness, the case is unproven outside higher-pressure, longer-session protocols. And at the mild end of the consumer market, benefits look incremental and cumulative rather than dramatic. As with most recovery tools, it layers on top of the unglamorous fundamentals rather than replacing them — the same pattern we saw when we looked at how small habits actually stick.
None of this is a recommendation for or against treatment, a diagnosis, or a purchase guide. Hyperbaric oxygen is a medical intervention with real contraindications, and anyone considering it — for an injury or otherwise — should start with a healthcare professional, the position set out in our medical disclaimer.